Picture of Ascletis Pharma logo

1672 Ascletis Pharma Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Ascletis Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-209-199-315-145
Depreciation
Amortisation
Non-Cash Items29.18.3182.8-132
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital6814.259.4114-342
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-84.9-147-142-144-342
Capital Expenditures-39-7.2-14.4-19.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items171-267-1,283169979
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities132-274-1,297150979
Financing Cash Flow Items-0.125-0.157-0.144-104
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-21.7-31.1-1.42-81.5-104
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-84.5-483-1,324-73.7534